Lachman has been providing
both onsite and remote
support to our clients
for many years.

Review Support Offerings

COVID-19 Survey Report:
A deeper look at the overall organizational and industry impact of the pandemic.

Read the Survey Report

Lachman Consultants Offers Support to Help U.S. Distilleries and Breweries Manufacture Hand Sanitizer.

Read the Full Story
The Lachman Difference

The most efficient services.
The most qualified professionals.

Since 1978, Lachman Consultants’ multidisciplinary team of highly experienced FDA and industry experts has offered compliance, regulatory affairs, and technical services to clients around the world.

Learn More About Us

Lachman Practice Groups

Three Practices
Executing One Vision

Lachman Consultants maintains three practice groups: Compliance, Regulatory Affairs, and Science and Technology. Each practice offers industry-leading experience and expertise in its area of focus.

Lachman OnCall Logo

Get the answers and guidance to your most pressing questions faster than ever before.

Now you can speak to one of our Subject Matter Experts and get the answers you need quickly on the many pressing issues arising in the life science areas that Lachman Consultants serves on a day to day basis. Whether it’s something you need to know about compliance, or a complex scientific or technical issue, Lachman OnCall™️ can provide you the timely information you require as needs arise and unforeseen questions occur.

Learn More About Lachman OnCall

OnCall Image

Recent Posts

The Lachman Consultants Blog

The latest on industry compliance, regulatory affairs, technical services, and a whole lot more.

White business graph with red and green lines

APPROVAL AND TENTATIVE APPROVAL ACTIONS NUMBER FOR ANDAS JULY 2020

As of August 5, 2020, the FDA had posted 69 full approval actions and ...
Read More

Webinar: Drug Supply Chain Security Act: Legal Overview and Cross-Enterprise Compliance Strategies (August 11, 2020 @1:00-2:00 PM ET)

In 2019, FDA issued the first Warning Letter for violations of the Dru...
Read More

Pharma’s Fight Against the Coronavirus Pandemic

A look at the pharma industry’s concerted effort to develop vaccines...
Read More

IID Ramping up MDE Information; More Help to Formulators on the Way

The Inactive Ingredient Database (IID) has been around for a long time...
Read More

Rebecca (Becky) Welton, new Senior Associate in the Regulatory Practice at Lachman Consultant Services, Inc.

We are pleased to announce that Rebecca Welton has accepted the positi...
Read More

History of the 503B Bulk Drug Substance List – We’ve Come A Long Ways in a Long Time….and the List Is Getting Longer and Longer?

As part of the Agency’s ongoing efforts to ensure patient’s access...
Read More
ADVANCE CONFIDENTLY
Contact Us Today